PRODUCT DISPLAY

Our company is committed to the research and production of high-purity animal and plant extracts, active pharmaceutical ingredients, cosmetic ingredients, and food additives

Cholic acid series products

Ursodeoxycholic acid, as an active pharmaceutical ingredient, can be used to increase bile acid secretion, alter bile composition, reduce cholesterol and cholesterol lipids in bile, and facilitate the gradual dissolution of cholesterol in gallstones.

Other products

It plays a leading and comprehensive role in anti-aging, antioxidant, anti radiation, beauty, liver protection, treatment of alcoholic liver disease and viral hepatitis, blood sugar control, and blood sugar concentration balance.

ABOUT BELLING

Zhongshan Belling Biotechnology Co., Ltd. was founded on April 6, 2004, located in the National Health Industry Base Park of Torch Development Zone, Zhongshan City, Guangdong Province, with a registered capital of 66.66 million RMB. It is a subsidiary of other limited liability companies. The company was recognized as a national high-tech enterprise in 2009, 2012, 2015, and 2018. In 2013, it was awarded the Guangdong Provincial Engineering Technology Research Center for Animal Medicinal Ingredients. In 2015, it successfully passed the new GMP certification for ursodeoxycholic acid. In May 2018, it was recognized as a provincial-level enterprise technology center in Guangdong Province. In August 2019, it obtained the EU CEP certificate.

20
50
50
1000

Focus on bile acid products

Products sold to countries and regions

Obtaining invention patents and certificates

Annual production of starting materials and active pharmaceutical ingredients

Year

Ton

+

Individual

About Belling

Development History

Business Scope

Our company is committed to the research and production of high-purity animal and plant extracts, active pharmaceutical ingredients, cosmetic raw materials, and food additives. Our leading product...

Our company is a leading enterprise in the domestic liver and gallbladder raw material products. Our company's excellent quality of ursodeoxycholic acid raw material has been widely recognized by domestic...

We look forward to long-term win-win cooperation with excellent international pharmaceutical companies to provide professional services for your products to enter the Chinese market.

GLOBAL MARKET

Belling Biological's bile acid products have been officially approved by China, Taiwan, China, the European Union, India, Russia and other countries, and have two EU CEP certificates for ursodeoxycholic acid. The factory has passed the on-site inspection by the US FDA. Every year, hundreds of tons of bile acid products are sold to nearly 50 countries and regions worldwide, including Germany, Russia, India, the United States, Canada, Japan, Argentina, Egypt, Australia, Brazil, and more. The product market share ranks among the top three globally.

LATEST NEWS

Follow Belling Biotechnology to learn more about the latest information on bile acid products

  • 上海交通大学基础医学院程金科课题组在一项最新研究中鉴定了肿瘤免疫抑制的重要调控因子SENP1,发现其通过影响MDSC的发育及功能改变肿瘤进程,并提示其在肿瘤临床治疗中的潜在价值。
    2024-08-02
  • 复旦大学药学院蒋晨课题组与上海医药工业研究院陆伟根课题组合作,研发出一种可重塑脑部病灶神经血管单元、治疗急性缺血型脑卒中、防止溶栓后副作用的新型聚合物胶束药物递送系统。
    2024-08-02
  • 日前,中科院生物物理所范祖森团队发现并鉴定了一类新的免疫细胞亚群:自然杀伤样B细胞(NKB cell)。他们还进一步探讨了这一类免疫细胞新亚群的发育来源,证明了NKB与B细胞从细胞发育来源上的不同。
    2024-08-02